PMDD: A Patient’s Perspective

At A Glance

• The article follows Sarah Gillespie’s six-year experience living with premenstrual dysphoric disorder, or PMDD.
• PMDD is presented as more severe than PMS and associated with substantial functional impairment.
• The article cites WHO recognition of PMDD as a gynecological disease and highlights global prevalence data.
• Multiple interventions did not provide Sarah lasting relief before she pursued surgery.
• Postsurgical improvement was significant for Sarah, though she says her trust in the healthcare system remains broken.

 

PMDD caused profound monthly disruption in Sarah Gillespie’s life.

FOR SIX long years, beginning in her late 20s, Sarah Gillespie lived under the shadow of a condition that few people had even heard of: premenstrual dysphoric disorder, or PMDD. Unlike premenstrual syndrome (PMS), which might cause mood swings or irritability, PMDD plunged Sarah into a state of physical and mental collapse every month. “Due to a genetic quirk,” she explains, “I have a brain sensitivity that makes my body intolerant to its own hormonal changes.”

This intolerance didn’t just affect her mood — it overtook her personality. During the latter half of each menstrual cycle, Sarah would become virtually unrecognizable to herself: “I became catatonic and racked with pain. Dysphoria bloomed in my brain, making me depressed and paranoid. I binged on carbohydrates, needing 3,000 calories a day just to function.”

Each episode lasted between seven and 14 days. Then, like clockwork, the fog would lift — but with clarity came devastation. “There were relationships to repair, overdue bills to pay and excess pounds to lose,” she recalled. “It was the life of Sisyphus: Every month, I roll the boulder up the mountain, only for it to roll down again.”

Key PMDD Symptoms and Monthly Functional Impact

• Sarah describes PMDD as a recurring condition that disrupted both physical and mental functioning.
• PMDD is distinguished from PMS by the severity of symptoms.
• Symptoms described in this section include pain, depression, paranoia and binge eating.
• The cyclical nature of PMDD created repeated personal, emotional and practical consequences.
• PMDD is identified as premenstrual dysphoric disorder.
• PMDD differs from PMS due to symptom severity and impact on daily functioning.
• Hormonal changes are described as a trigger for Sarah’s recurring symptoms.

 

PMDD is described as a recognized condition with substantial global burden.

According to data from the World Health Organization (WHO), PMDD affects 5.5 percent of women of childbearing age. Alarmingly, more than a third of those diagnosed have attempted suicide. In 2022, WHO classified PMDD as a recognized gynecological disease, distinguished from PMS by the severity of its symptoms and their impact on functioning.¹ In addition, a recent study led by Thomas Reilly, BSc (Med Sci), MBChB, MRCPsych, at the University of Oxford’s Department of Psychiatry estimates that approximately 31 million women and girls suffer from PMDD globally.²

PMDD Prevalence, Global Burden and WHO Disease Classification

• WHO data estimates PMDD affects 5.5 percent of women of childbearing age.
• WHO is cited as classifying PMDD as a recognized gynecological disease in 2022.
• PMDD symptoms can significantly impair daily functioning.
• A University of Oxford study is cited to estimate that approximately 31 million women and girls are affected globally.

 

Sarah’s path through diagnosis and treatment was prolonged and difficult.

The findings do little to ease Sarah’s memories of her own frustrating journey through the healthcare maze. After years of suffering, Sarah finally received a diagnosis and began a series of progressive interventions. From supplements like chasteberry and magnesium to contraceptives, antidepressants and, eventually, hormone replacement therapy, nothing provided lasting relief. As her body aged and her hormones grew even more erratic, her condition actually worsened.

PMDD Diagnosis and Initial Treatment Approaches

• Sarah’s diagnosis came after years of suffering.
• Treatment attempts progressed through supplements, contraceptives, antidepressants and hormone replacement therapy.
• None of the interventions in this section provided lasting relief.
• Sarah reports that her condition worsened over time.

 

Bilateral salpingo-oophorectomy was presented as a last-resort treatment decision.

Having exhausted other treatment options, Sarah made the difficult decision to request a bilateral salpingo-oophorectomy — surgical removal of her ovaries and fallopian tubes. It was a drastic choice, but one with a 96 percent satisfaction rate among those with severe PMDD.³ “I was advised that following surgery, all hormone fluctuations would stop,” she said. “I would enter menopause and need hormone replacement therapy until my 50s. It would also make me infertile.”

Surgical Treatment for Severe PMDD: Bilateral Salpingo-Oophorectomy

• Sarah pursued surgery only after other treatment options had been exhausted.
• The procedure is identified as bilateral salpingo-oophorectomy, involving removal of the ovaries and fallopian tubes.
• Bilateral salpingo-oophorectomy shows a reported 96 percent satisfaction rate among individuals with severe PMDD.
• The consequences described include menopause, hormone replacement therapy and infertility.

Treatment Landscape Summary

PMDD

• Interventions attempted before surgery included supplements, contraceptives, antidepressants and hormone replacement therapy.
• Bilateral salpingo-oophorectomy is described as a last-resort treatment after other approaches failed.

Shared considerations

• The treatment path described in the article reflects escalation after inadequate symptom control.
• Treatment decisions were influenced by hormone fluctuations, symptom severity and quality-of-life impact.

 

Access barriers and clinical dismissal intensified Sarah’s experience.

For Sarah, even this last-resort treatment wasn’t easy to access. First, she endured a trial period of chemical menopause via monthly injections. Rather than providing relief, the injections triggered a continuous 11-month PMDD episode. “I languished in bed and gulped down painkillers and sleeping pills like candy,” she explained. Her physical and mental health also crumbled, and her trust in the medical system was deeply shaken. One physician dismissed her condition entirely, saying, “If it hasn’t worked, that suggests it’s not PMDD… I should probably refer you to a psychiatrist.”

After months of begging, she was finally referred to a surgeon — but the assumption that the condition was all in her head lingered, and her procedure was denied. Undeterred, she says the Internet became her lifeline — not for support groups, but for science. She dug through medical journals to validate her desire for surgery, and her research led her to a European clinic that offered bilateral salpingo-oophorectomy. Sarah contacted the Nordclinic in Kaunas, Lithuania, forwarded them her medical records and was relieved when the staff surgeon agreed to operate.

Healthcare Access Challenges and Diagnostic Dismissal in PMDD

• Sarah underwent a trial of chemical menopause before surgery.
• Monthly injections intended to induce chemical menopause triggered a continuous 11-month PMDD episode.
• Clinical dismissal and denied care are presented as major parts of her healthcare experience.
• Sarah turned to medical literature and ultimately sought surgery at Nordclinic in Kaunas, Lithuania.

Case Study Insights

• The case highlights how treatment access can remain difficult even after diagnosis.
• Prolonged symptoms contributed to deterioration in physical health, mental health and trust in care systems.
• Sarah’s experience emphasizes the role of self-education and persistence in navigating complex care decisions.

 

Surgery brought major symptom relief, but the long-term impact of PMDD remained.

For Sarah, the postsurgical transformation was almost immediate: “I still can’t believe how well I feel. My future unfurls before me without interruption. I have so much time now: time to write, to see friends and family, to travel, go on dates, paint and sing and read and run. Time to cook, as I can now handle knives without fear of self-harm.”

Today, Sarah is no longer at war with her own body. And for the first time in years, she is looking forward without dread: “I don’t need to keep starting again and again and again every month. Life without PMDD is so, so wonderful.”

Still, Sarah remained deeply affected by the years she lost to PMDD. “I still need to reckon with all the time taken from me over the past six years,” she says. “My trust in our healthcare system is broken and will probably never be restored.”

Post-Surgical Outcomes and Long-Term Impact of PMDD

• Sarah describes rapid improvement after surgery.
• Post-surgical relief included restored daily functioning, improved safety and regained personal time.
• The emotional burden of years lived with PMDD remains part of her experience.
• Despite improvement, Sarah says her trust in the healthcare system has not been restored.

 

Frequently Asked Questions

What does PMDD feel like?

PMDD is associated with severe emotional and physical symptoms that occur during the luteal phase of the menstrual cycle, typically in the one to two weeks before menstruation. Symptoms may include intense depression, anxiety, irritability, fatigue, pain, changes in appetite and difficulty functioning in daily life. These symptoms usually improve once menstruation begins.

What is the best treatment for PMDD?

There is no single treatment that works for everyone with PMDD. Management may include lifestyle changes, nutritional supplements, hormonal contraceptives, antidepressant medications or hormone therapies. In severe cases that do not respond to other treatments, surgical removal of the ovaries may be considered to stop hormone fluctuations.

Is PMDD considered a mental illness?

PMDD is classified as a depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). At the same time, it is also recognized as a gynecological condition linked to sensitivity to hormonal changes during the menstrual cycle. As a result, PMDD is often viewed as a disorder that involves both psychiatric and reproductive health components.

At what age does PMDD get worse?

PMDD symptoms often begin in the late teens or early adulthood. For some individuals, symptoms may intensify during the late reproductive years when hormonal fluctuations become more pronounced, particularly in the years leading up to menopause.

What can PMDD be mistaken for?

PMDD can be mistaken for several conditions because many symptoms overlap with other mood and psychiatric disorders. These may include major depressive disorder, generalized anxiety disorder, bipolar disorder or severe premenstrual syndrome (PMS). Careful tracking of symptoms across multiple menstrual cycles is often used to distinguish PMDD from other conditions.

Is PMDD a disability?

PMDD can cause severe functional impairment for some individuals, affecting work, relationships and daily activities. In certain circumstances, the condition may qualify as a disability depending on the severity of symptoms and the criteria used by specific employers, insurance systems or disability programs.

How do they check for PMDD?

Diagnosis is typically based on symptom history and prospective tracking of symptoms across at least two menstrual cycles. Clinicians look for a clear pattern in which symptoms appear during the luteal phase and improve shortly after menstruation begins. Other medical or psychiatric conditions are also evaluated to rule out alternative explanations.

What is the root cause of PMDD?

PMDD is believed to result from an abnormal sensitivity to normal hormonal changes during the menstrual cycle. Research suggests that fluctuations in estrogen and progesterone may affect neurotransmitters in the brain, particularly serotonin, which influences mood and emotional regulation.

What kind of doctor treats PMDD?

PMDD may be managed by several types of clinicians depending on symptom severity and treatment needs. These may include gynecologists, psychiatrists, primary care physicians and endocrinologists. Care often involves collaboration between reproductive health and mental health specialists.

Can PMDD go away?

PMDD symptoms typically resolve after menopause because menstrual hormone fluctuations stop. Some individuals may also experience improvement with effective medical treatment that stabilizes hormonal changes or addresses mood-related symptoms.

 

Related BSTQ Coverage

Explore related coverage:

• Update on Premenstrual Dysphoric Disorder (PMDD)
• PMDD: A Physician’s Perspective